Doping Journal Noteworthy Articles

Noteworthy section of the Doping Journal (ISSN 1812-948x) alerts interested readers about the selected noteworthy original research and viewpoint/review articles, book reviews, and meeting reports (published in other journals) on the subject of the Doping Journal scope.

DJ Home | Noteworthy home | DJ Content | Archiving your research in DJ is a new service by the Doping Journal DJ archive | Mission | PubMed | IFORA | Affiliates  | Contact us
We work for athletes, not corrupted antidoping officials, donate now to help us

July 9, 2007

Induction of micronuclei in V79 cells by the anabolic doping steroids

Dorn SB, Bolt HM, Thevis M, Diel P, Degen GH.
Leibniz Research Centre for Working Environment and Human Factors, Institut fur Arbeitsphysiologie an der Universitat Dortmund (IfADo), Ardeystr. 67, 44139, Dortmund, Germany
PubMed ID & Record:
17764006

The synthetic steroid tetrahydrogestrinone is a new "designer drug" and was recently detected to be illegally used in sports. It is chemically closely related to trenbolone that is known as an animal growth promoter. The potencies of trenbolone, tetrahydrogestrinone and testosterone to induce micronuclei in V79 cells in vitro were determined. CREST analysis was employed to differentiate between aneugenic or clastogenic mechanisms. Cytotoxicity and an influence on the cell cycle were assessed in parallel. Incubations with testosterone, at concentrations between 3 and 300 muM, failed to induce micronuclei. By contrast, tetrahydrogestrinone and trenbolone increased the rate of micronuclei significantly, up to a doubling of the micronuclei rate of untreated controls. Tetrahydrogestrinone and trenbolone displayed a bell-shaped dose-response curve, with maximal effects observed at 3 and 30 muM, respectively. The micronuclei induced by tetrahydrogestrinone and trenbolone were predominantly kinetochor (CREST) positive, pointing to an aneugenic mode of action. This may be related to the specific structure of both molecules with a system of activated double bonds. As the genotoxic effect of tetrahydrogestrinone at a chromosomal level appears at a low concentration range, it cannot be ruled out that tetrahydrogestrinone presents a genotoxic hazard on a chromosomal level under conditions of its current misuse in sports.

0 Comments:

Post a Comment

<< Home

DJ Home | Noteworthy home | DJ Content | Archiving your research in DJ is a new service by the Doping Journal DJ archive | Mission | PubMed | IFORA | Affiliates | Contact us